ArticleThe Laryngoscope2026
Trends in Industry-Sponsored Research Payments to Otolaryngologist Principal Investigators.
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesResearch payments constitute the largest payment category in the Centers for Medicare and Medicaid Services (CMS) Open Payments program (OPP). We sought to characterize the distributions of and trends in industry-sponsored research payments (ISRPs) to otolaryngologists.
methodsOPP data was used to identify ISRPs to otolaryngologists between January 1, 2015 and December 31, 2023. ISRPs were stratified by recipient entity as covered teaching hospitals, covered physicians, and non-covered entities (NCEs) and evaluated using descriptive analysis and multivariable linear regression.
resultsISRPs increased 132% from $15.6 million in 2015 to $36.2 million in 2023 (p < 0.001). Payments to NCEs with an otolaryngologist principal investigator (PI) constituted most payments (80%). Male otolaryngologist PIs decreased by -0.2%, while female otolaryngologist PIs increased by 86% (p < 0.01). Annual median payment values per otolaryngologist PI within NCEs increased 111% from $15,239 in 2015 to $32,097 in 2023 (p < 0.001). Among male otolaryngologist PIs within NCEs, total ISRPs increased 109% from $12.9 million in 2015 to $27.0 million in 2023, and median payment value per PI increased 93% from $17,144 in 2015 to $33,155 in 2023 (p < 0.01). Among female otolaryngologist PIs within NCEs, total ISRPs increased 125% from $0.5 million in 2015 to $1.1 million in 2023, but median payment value per PI only increased 14% from $11,973 in 2015 to $13,614 in 2023 (p = 0.1).
conclusionsISRPs to otolaryngologists more than doubled from 2015 to 2023, with most payments directed to PIs within NCEs. Median payments to female otolaryngology PIs did not increase, despite an increase in female otolaryngologist PIs. LEVEL OF EVIDENCE: N/A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.